A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours. [electronic resource]
Producer: 20131115Description: 1085-92 p. digitalISSN:- 1532-1827
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor -- blood
- Disease-Free Survival
- Docetaxel
- Female
- Gonanes -- adverse effects
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasms -- drug therapy
- Phosphoinositide-3 Kinase Inhibitors
- Taxoids -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.